isoniazid and fropenem
isoniazid has been researched along with fropenem in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Castagnolo, D; Denny, WA; Dos Santos, JL; Fernandes, GFS; Thompson, AM | 1 |
| Arthur, M; Ballell, L; Barros, D; Cuinet, G; Dhar, N; Dubée, V; Hugonnet, JE; McKinney, JD; Signorino-Gelo, F | 1 |
Reviews
1 review(s) available for isoniazid and fropenem
| Article | Year |
|---|---|
Tuberculosis Drug Discovery: Challenges and New Horizons.
Topics: Antitubercular Agents; COVID-19 Drug Treatment; Drug Discovery; Humans; Mycobacterium tuberculosis; Tuberculosis | 2022 |
Other Studies
1 other study(ies) available for isoniazid and fropenem
| Article | Year |
|---|---|
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic.
Topics: Antitubercular Agents; beta-Lactams; Isoniazid; Mycobacterium tuberculosis; Peptidyl Transferases | 2015 |